Top Markets
Coin of the day
Carbiotix AB Carbiotix AB

Carbiotix AB

CRBX
Rank in Stocks #35613
Carbiotix AB is a therapeutics company currently in the pre-clinical... Carbiotix AB is a therapeutics company currently in the pre-clinical development stage. It specializes in creating products and medicines intended to stimulate beneficial bacteria in the gut, with the aim of addressing metabolic and chronic illnesses. The company was established in 2014 and is headquartered in Lund, Sweden.
Share Price
$0.73494346
Last synced: 2025-12-15
Market Cap
$3.66M
Change (1 day)
18.28%
Change (1 year)
-29.75%
Country
SE
Trade Carbiotix AB (CRBX)

Category

Revenue for Carbiotix AB (CRBX)
Revenue in Aug 2026 TTM: 0
According to Carbiotix AB latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Carbiotix AB from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$11.26B -
US
- -
CA
$4.64B -
US
$7.03B -
AU
$19.85B -
US